Maze Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2026-Q1 and 2026-Q2. According to the most recent SEC 13F filing, 4 superinvestors own shares of Maze Therapeutics Inc (MAZE), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Maze Therapeutics Inc (MAZE), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Maze Therapeutics Inc (MAZE) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Maze Therapeutics Inc (MAZE) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Amy C Hui@Y-intercept (hong Kong) Ltd
| 0.01% | $428,801 14,370 shares@ 29.85 avg price | Decreased -33.86% |
Rachel Vonbank@Falcon Wealth Planning
| 0.02% | $287,359 9,630 shares@ 29.84 avg price | Decreased -0.09% |
Lorraine Fang@Gamma Investing Llc
| 0.01% | $5,073 170 shares@ 29.85 avg price | Decreased -51.7% |
Todd Hyatt@Torren Management, Llc
| 0.01% | $3,342 112 shares@ 29.84 avg price |
1-4 of 4